150 related articles for article (PubMed ID: 12439921)
1. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.
Zeng WJ; Liu GY; Xu J; Zhou XD; Zhang YE; Zhang N
World J Gastroenterol; 2002 Dec; 8(6):1040-4. PubMed ID: 12439921
[TBL] [Abstract][Full Text] [Related]
2. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
Saiki I; Une Y; Uchino J
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
[TBL] [Abstract][Full Text] [Related]
3. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis.
Kitamoto M; Nakanishi T; Kira S; Kawaguchi M; Nakashio R; Suemori S; Kajiyama G; Asahara T; Dohi K
Cancer; 1993 Sep; 72(6):1859-65. PubMed ID: 8103417
[TBL] [Abstract][Full Text] [Related]
4. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
Nakai S; Masaki T; Shiratori Y; Ohgi T; Morishita A; Kurokohchi K; Watanabe S; Kuriyama S
Int J Oncol; 2002 Apr; 20(4):769-75. PubMed ID: 11894123
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.
Hu TH; Wang CC; Huang CC; Chen CL; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Tai MH
Oncol Rep; 2007 Dec; 18(6):1417-26. PubMed ID: 17982625
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic features and prognosis of resected hepatocellular carcinomas of varied sizes with special reference to proliferating cell nuclear antigen.
Suehiro T; Matsumata T; Itasaka H; Yamamoto K; Kawahara N; Sugimachi K
Cancer; 1995 Aug; 76(3):399-405. PubMed ID: 8625120
[TBL] [Abstract][Full Text] [Related]
7. Proliferating cell nuclear antigen (PCNA) activity in hepatocellular carcinoma, benign peri-neoplastic and normal liver.
Mun KS; Cheah PL; Baharudin NB; Looi LM
Malays J Pathol; 2006 Dec; 28(2):73-7. PubMed ID: 18376794
[TBL] [Abstract][Full Text] [Related]
8. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia.
Adachi E; Hashimoto H; Tsuneyoshi M
Cancer; 1993 Nov; 72(10):2902-9. PubMed ID: 8106139
[TBL] [Abstract][Full Text] [Related]
9. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
Luo HY; Wang HC; Feng DY
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):17-9. PubMed ID: 12934386
[TBL] [Abstract][Full Text] [Related]
10. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
Hino N; Higashi T; Nouso K; Nakatsukasa H; Urabe Y; Kinugasa N; Yoshida K; Ashida K; Ohguchi S; Tsuji T
Hepatogastroenterology; 1997; 44(13):245-50. PubMed ID: 9058153
[TBL] [Abstract][Full Text] [Related]
11. Cellular apoptosis susceptibility protein and proliferation in human hepatocellular carcinoma.
Shiraki K; Fujikawa K; Sugimoto K; Ito T; Yamanaka T; Suzuki M; Yoneda K; Sugimoto K; Takase K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):77-81. PubMed ID: 16786158
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of proliferating cell nuclear antigen in primary hepatocellular carcinoma and dysplastic nodules.
Saftoiu A; Ciurea T; Georgescu C; Banita M; Comanescu V; Rogoveanu I; Gorunescu F; Georgescu I
J Cell Mol Med; 2003; 7(4):436-46. PubMed ID: 14754512
[TBL] [Abstract][Full Text] [Related]
13. In human hepatocellular carcinoma in cirrhosis proliferating cell nuclear antigen (PCNA) is involved in cell proliferation and cooperates with P21 in DNA repair.
Gramantieri L; Trerè D; Chieco P; Lacchini M; Giovannini C; Piscaglia F; Cavallari A; Bolondi L
J Hepatol; 2003 Dec; 39(6):997-1003. PubMed ID: 14642618
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N
Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
16. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
[TBL] [Abstract][Full Text] [Related]
18. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival.
Nakamura T; Tabuchi Y; Nakae S; Ohno M; Saitoh Y
Cancer; 1996 Apr; 77(8 Suppl):1741-6. PubMed ID: 8608572
[TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma.
Shen SQ; Li K; Zhu N; Nakao A
Med Oncol; 2008; 25(3):341-5. PubMed ID: 18214716
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma.
Ng IO; Lai EC; Fan ST; Ng M; Chan AS; So MK
Cancer; 1994 May; 73(9):2268-74. PubMed ID: 7513246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
